D. O. Morgan

发表

IgM antibody--II. The isolation and characterization of equine J chain.

F. Karush, K. Mitchell, D. O. Morgan, 1977, Immunochemistry.

IgM antibody--I. Heterogeneity of the component chains of equine anti-lactose antibody.

F. Karush, K. Mitchell, D. O. Morgan, 1977, Immunochemistry.

The Design of a Continuous Flow Combinatorial Screening Micro Reactor System with On-Chip Detection

Stephanie Y. F. Wong, S. Haswell, P. Styring, 2000 .

Experiments with [9,10,12,13-2H4]linoleic acid on the formation of 9-[nona-(1′E),(3′Z)-dienyloxy]non-(8E)-enoic (colneleic) acid and (13R)-hydroxy-12-oxo-octadec-(9Z)-enoic acid by plant enzymes

L. Crombie, D. O. Morgan, 1987 .

The enzymic formation of colneleic acid, a divinyl ether fatty acid: experiments with [(9S)-18O2]hydroperoxyoctadeca-(10E),(12Z)-dienoic acid

L. Crombie, D. O. Morgan, E. H. Smith, 1987 .

An isotopic study (2H and 18O) of the enzymic conversion of linoleic acid into colneleic acid with carbon chain fracture: the origin of shorter chain aldehydes

L. Crombie, D. O. Morgan, E. H. Smith, 1991 .

Preparation and Cycloaddition Reactions of Novel Heterocyclic Mesomeric Betaines

W. Ollis, S. Stanforth, D. O. Morgan, 2000 .

The Development of a Manufacturing Route for the GPIIb/IIIa Receptor Antagonist SB-214857-A. Part 2: Conversion of the Key Intermediate SB-235349 to SB-214857-A

Gary Francis GlaxoSmithKline Breen, A. Wells, J. S. Carey, 2003 .

A mild and efficient method for the formation of a key intermediate in penem chemistry

D. O. Morgan, N. Hussain, 1995 .

Alkoxy radicals in organic synthesis. A novel approach to a key intermediate in milbemycin chemistry

John A. Murphy, D. O. Morgan, N. Hussain, 1994 .

Synthesis of an α-(aminooxy)arylacetic ester by the reaction of an α-diazo ester with n-hydroxyphthalimide

D. O. Morgan, D. Lathbury, K. Ace, 1995 .

Development of an Efficient and Stereoselective Manufacturing Route to Idoxifene

D. O. Morgan, D. Lathbury, R. Bellingham, 2001 .

Spiroacetal synthesis from a key lactone intermediate leading to novel C24 and C25-substituted milbemycins

Graham S. Macaulay, G. Baker, D. O. Morgan, 1994 .

The use of a novel microreactor for high throughput continuous flow organic synthesis

Peter Styring, Gillian M. Greenway, Stephen J. Haswell, 2000 .

Synthesis of [14,14-2H2]-linolenic acid and its use to confirm the pathway to 12-oxophytodienoic acid (12-oxoPDA) in plants: a conspectus of the epoxycarbonium ion derived family of metabolites from linoleic and linolenic acid hydroperoxides

L. Crombie, D. O. Morgan, 1991 .

Formation of acyclic α- and γ-ketols and 12-oxophytodienoic acid from linolenic acid 13-hydroperoxide by a flax enzyme preparation. Evidence for a single enzyme leading to a common allene epoxide intermediate

L. Crombie, D. O. Morgan, 1988 .

The conversion of linoleic acid (13S)-hydroperoxide into (13R)-hydroxy-12-oxo-octadec-(9Z)-enoic acid and 9-hydroxy-12-oxo-octadec-(10E)-enoic acid by a flax enzyme. Isotopic evidence for allene epoxide intermediates

L. Crombie, D. O. Morgan, 1988 .

A new synthesis of the GPIIb/IIIa receptor antagonist SB-214857-A

Gary Francis GlaxoSmithKline Breen, A. Wells, Stephen A. Smith, 2001 .

Micro-reactor synthesis: synthesis of cyanobiphenyls using a modified Suzuki coupling of an aryl halide and aryl boronic acid

Peter Styring, Gillian M. Greenway, Stephen J. Haswell, 2000 .

Protein-linked Ubiquitin Chain Structure Restricts Activity of Deubiquitinating Enzymes*

D. O. Morgan, Jonathan b. Schaefer, 2011, The Journal of Biological Chemistry.

The preparation of a series of nitrostilbene ester compounds using micro reactor technology.

Stephanie Y. F. Wong, G M Greenway, S. Haswell, 2001, The Analyst.

The generation of concentration gradients using electroosmotic flow in micro reactors allowing stereoselective chemical synthesis.

Stephanie Y. F. Wong, G M Greenway, B H Warrington, 2001, The Analyst.

The investigation of an equilibrium dependent reaction for the formation of enamines in a microchemical system.

S. Haswell, P. Styring, V Skelton, 2001, Lab on a chip.

The Development of a Manufacturing Route for the GPIIb/IIIa Receptor Antagonist SB-214857-A. Part 1: Synthesis of the Key Intermediate 2,3,4,5-Tetrahydro-4-methyl-3-oxo-1H-1,4-benzodiazepine-2-acetic Acid Methyl Ester, SB-235349

Gary Francis GlaxoSmithKline Breen, A. Wells, Stephen A. Smith, 2003 .